News

Anne Wojcicki’s nonprofit reaches deal to acquire 23andMe
Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...
Biotech company Regeneron to buy bankrupt 23andMe for $256M
Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...
23andMe co-founder Anne Wojcicki regains control of bankrupt genetic testing company
Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of the DNA-testing company she co-founded.
Pharma giant Regeneron to buy 23andMe and its customers’ data for $256M
Regeneron said it will acquire 23andMe’s genomics service and its bank of 15 million customers’ personal and genetic data as part of the deal. The pharma giant said it plans to use the 23andMe ...
Hosted on MSN23d
Does the 23andMe Acquisition Make Regeneron a Buy Now?
Is Regeneron a good stock to buy now in light of a potential 23andMe acquisition? Here's a quick look at what it's paying for to find out. What Regeneron could get for $256 million 23andMe's ...
The Journal News29d
Regeneron to acquire 23andMe DNA testing firm. How that could impact your genetic data
Regeneron's co-founder, Dr. George D. Yancopoulos, who is also the company's president and chief scientific officer, described the 23andMe acquisition as part of Regeneron's strategy to use ...
ConsumerAffairs6d
States file suit to block the sale of 23andMe data
D.C. sue to block 23andMe's data sale amid bankruptcy proceedings. Regeneron Pharmaceuticals' $256 million acquisition faces ...